The [[pharmacology]] of melitracen has not been properly investigated and is largely unknown, but it is likely to act in a similar manner to other TCAs. Indeed, melitracen is reported to have [[imipramine]] and [[amitriptyline]]-like effects and efficacy against depression and anxiety, though with improved [[tolerability]] and a somewhat faster [[onset of action]].<ref name="isbn0-444-53266-8">{{cite book | author = Aronson, Jeffrey Kenneth | title = Meyler's Side Effects of Psychiatric Drugs (Meylers Side Effects) | publisher = Elsevier Science | location = Amsterdam | year = 2008 | pages = | isbn = 0-444-53266-8 | oclc = | doi = | url = https://books.google.com/?id=s0XYvuPVgaAC&lpg=PA34&dq=melitracen%20amitriptyline&pg=PA34#v=onepage&q=}}</ref><ref name="isbn0-12-040505-9">{{cite book | author = Author Unknown | title = Ann Reports Medicinal Chem V5 (v. 5) | publisher = Academic Press | location = Boston | year = 1970 | pages = | isbn = 0-12-040505-9 | oclc = | doi = | url = https://books.google.com/?id=JIdV5T356CQC&lpg=PA13&dq=melitracen%20amitriptyline&pg=PA13#v=onepage&q=melitracen}}</ref>
